Alnylam Pharmaceuticals Stock News

The biopharmaceutical company shows bullish charts that signal a breakout to new all-time highs. The charts and indicators are bullish,

Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters revi

Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters revi

QUANTUM WORKPLACE HONORS FOUR COMPANIES WITH ITS ANNUAL EMPLOYEE VOICE AWARD

“I would not be surprised if we go up to 100,000 a day if this does not turn around. And so I am very concerned” --Fauci

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the presentation of new data from the open-label extension (OLE) period of the ENVISION Phase 3 stu

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the presentation of new data from the open-label

GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...

1832 Asset Management L.P. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) during the 1st quarter, according to the company in its most recent disclosure with the Securities and E

The number of new confirmed cases of the coronavirus illness COVID-19 set another fresh record in the U.S. on Friday, according to data aggregated by Johns...

The number of new confirmed cases of the coronavirus illness COVID-19 set a fresh record in the U.S. on Thursday of almost 40,000, according to data...

Gilead has indicated that it would be starting clinical trials for an inhaled version of Remdesivir shortly. While the wide-spectrum anti-viral drug is currently given intravenously for severe cases o

Higher numbers of COVID-19 cases helped these biotechs, which are working on treatments and vaccines for the disease.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) ACADIA Pharmaceuticals Inc...

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) ADC Therapeutics SA (...